Insiders · Profile

Gault Cheryl

Chief Operating Officer at Rapport Therapeutics. Filing since 8 Sep 2025. CIK 0001839046

Company
Date
Role
Action
Shares
Amount
Of holding
30 Sep 2026
Chief Operating Officer
Sold on a plan
10,000
$331.86K
6.7%
30 Jun 2026
Chief Operating Officer
Sold on a plan
10,000
$415.80K
6.3%
30 Mar 2026
Chief Operating Officer
Sold on a plan
10,000
$281.86K
5.9%
5 Mar 2026
Chief Operating Officer
Sold at will
2,014
$58.27K
1.2%
26 Nov 2025
Chief Operating Officer
Sold on a plan
5,000
$150.49K
2.8%
8 Sep 2025
Chief Operating Officer
Sold on a plan
5,000
$191.65K
2.8%
6 decisions on file.